Jan 09, 2025 18:00
SPRB - Spruce Biosciences, Inc. Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 105.0 2.27 (2.16%) | 0.08 (0.07%) | 0.31 (0.29%) | -0.1 (-0.09%) | -3.0 (-2.86%) | 6.17 (6.1%) | -3.25 (-3.09%) | -3.3 (-3.13%) |
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT), and Tildacerfont/ Cortibon, a Companion Diagnostic, developed in partnership with HMNC Brain Health.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Market
Earnings & Ratios
- Basic EPS:
- -0.32
- Diluted EPS:
- -0.32
- Basic P/E:
- -335.2188
- Diluted P/E:
- -335.2188
- RSI(14) 1m:
- 55.88
- VWAP:
- 107.21
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
May 13, 2024 21:10
May 01, 2024 11:55
Mar 27, 2024 16:00
Mar 21, 2024 14:20
Mar 14, 2024 20:15
Mar 14, 2024 18:46
Mar 14, 2024 17:38
Mar 14, 2024 16:14
Mar 14, 2024 13:46